Sirnaomics Receives NCI Grant to Develop siRNA-Based Lung Cancer Rx
July 23rd, 2009
Sirnaomics this week announced that it has received a Small Business Innovation Research grant from the National Cancer Institute to develop novel siRNA-based therapeutics for lung cancer.